Treace Medical Concepts Stock Z Score
| TMCI Stock | USD 8.43 0.46 5.77% |
Treace | Z Score |
Treace Medical Concepts Company Z Score Analysis
Treace Medical's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Treace Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Treace Medical is extremely important. It helps to project a fair market value of Treace Stock properly, considering its historical fundamentals such as Z Score. Since Treace Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Treace Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Treace Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
Based on the company's disclosures, Treace Medical Concepts has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Treace Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Treace Medical from analyzing Treace Medical's financial statements. These drivers represent accounts that assess Treace Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Treace Medical's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Enterprise Value | 1.3B | 933.5M | 1.3B | 833.2M | 520.4M | 494.4M |
Treace Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Treace Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Treace Medical's managers, analysts, and investors.Environmental | Governance | Social |
Treace Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Treace Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Treace Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Treace Medical's value.| Shares | Ubs Group Ag | 2024-12-31 | 968.4 K | State Street Corp | 2024-12-31 | 966.4 K | Kornitzer Capital Management Inc | 2024-12-31 | 526.9 K | Gagnon Advisors, Llc | 2024-12-31 | 489.9 K | Nuveen Asset Management, Llc | 2024-12-31 | 472.8 K | Northern Trust Corp | 2024-12-31 | 468.9 K | Goldman Sachs Group Inc | 2024-12-31 | 464.8 K | Charles Schwab Investment Management Inc | 2024-12-31 | 349.5 K | Millennium Management Llc | 2024-12-31 | 328.8 K | Armistice Capital, Llc | 2024-12-31 | 6.2 M | Blackrock Inc | 2024-12-31 | 3.8 M |
Treace Fundamentals
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (0.27) % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 493.05 M | ||||
| Shares Outstanding | 62.62 M | ||||
| Shares Owned By Insiders | 26.03 % | ||||
| Shares Owned By Institutions | 60.61 % | ||||
| Number Of Shares Shorted | 2.26 M | ||||
| Price To Book | 4.42 X | ||||
| Price To Sales | 2.38 X | ||||
| Revenue | 209.36 M | ||||
| Gross Profit | 168.26 M | ||||
| EBITDA | (42.07 M) | ||||
| Net Income | (55.74 M) | ||||
| Cash And Equivalents | 101.53 M | ||||
| Cash Per Share | 1.83 X | ||||
| Total Debt | 69.65 M | ||||
| Debt To Equity | 0.99 % | ||||
| Current Ratio | 8.13 X | ||||
| Book Value Per Share | 1.81 X | ||||
| Cash Flow From Operations | (37.17 M) | ||||
| Short Ratio | 6.20 X | ||||
| Earnings Per Share | (0.90) X | ||||
| Target Price | 11.29 | ||||
| Number Of Employees | 477 | ||||
| Beta | 0.78 | ||||
| Market Capitalization | 499.07 M | ||||
| Total Asset | 217.09 M | ||||
| Retained Earnings | (189.99 M) | ||||
| Working Capital | 126.48 M | ||||
| Net Asset | 217.09 M |
About Treace Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Treace Medical Concepts's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Treace Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Treace Medical Concepts based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:Check out Treace Medical Piotroski F Score and Treace Medical Valuation analysis. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share | Quarterly Revenue Growth 0.104 | Return On Assets | Return On Equity |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.